Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DASATINIB vs DEFEROXAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DASATINIB vs DEFEROXAMINE: Safety Overview

Metric DASATINIB DEFEROXAMINE
Total FAERS Reports 30,019 839
Deaths Reported 2,681 152
Death Rate 8.9% 18.1%
Hospitalizations 6,437 314
Average Patient Age 56.4 yrs 41.9 yrs
% Female Patients 51.9% 59.1%
FDA Approval Date Apr 22, 2025 Approved Prior to Jan 1, 1982
Manufacturer Zydus Pharmaceuticals USA Inc. Novartis Pharmaceuticals Corporation
Route ORAL INTRAMUSCULAR
Marketing Status Prescription Prescription